ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32470-10mg |
|
303-97-9 |
Coenzyme Q9 (Ubiquinone Q9)
|
0 | C54H82O4 | |
GC32470-5mg |
|
303-97-9 |
Coenzyme Q9 (Ubiquinone Q9)
|
0 | C54H82O4 | |
GC32470-1mg |
|
303-97-9 |
Coenzyme Q9 (Ubiquinone Q9)
|
0 | C54H82O4 | |
GC32469-25mg |
|
15966-93-5 |
SU5408 (VEGFR2 Kinase Inhibitor I)
|
0 | C18H18N2O3 | |
GC32469-10mg |
|
15966-93-5 |
SU5408 (VEGFR2 Kinase Inhibitor I)
|
0 | C18H18N2O3 | |
GC32469-5mg |
|
15966-93-5 |
SU5408 (VEGFR2 Kinase Inhibitor I)
|
0 | C18H18N2O3 | |
GC32469-1mg |
|
15966-93-5 |
SU5408 (VEGFR2 Kinase Inhibitor I)
|
0 | C18H18N2O3 | |
GC32469-10mM(1mLinDMSO) |
|
15966-93-5 |
SU5408 (VEGFR2 Kinase Inhibitor I)
|
0 | C18H18N2O3 | |
GC32468-10mg |
|
— |
Lanatoside C
|
0 | — | |
GC32468-10mM(1mLinDMSO) |
|
— |
Lanatoside C
|
0 | — | |
GC32467-500mg |
|
117-37-3 |
Anisindione
|
0 | C16H12O3 | |
GC32467-100mg |
|
117-37-3 |
Anisindione
|
0 | C16H12O3 | |
GC32467-10mM(1mLinDMSO) |
|
117-37-3 |
Anisindione
|
0 | C16H12O3 | |
GC32466-50mg |
|
949100-39-4 |
Delcasertib (KAI-9803)
|
0 | C180H199N45O34S2 | |
GC32466-25mg |
|
949100-39-4 |
Delcasertib (KAI-9803)
|
0 | C180H199N45O34S2 | |
GC32466-10mg |
|
949100-39-4 |
Delcasertib (KAI-9803)
|
0 | C180H199N45O34S2 | |
GC32466-5mg |
|
949100-39-4 |
Delcasertib (KAI-9803)
|
0 | C180H199N45O34S2 | |
GC32466-10mM(1mLinDMSO) |
|
949100-39-4 |
Delcasertib (KAI-9803)
|
0 | C180H199N45O34S2 | |
GC32465-100mg |
|
959551-10-1 |
NIH-12848
|
0 | C20H14F3N3S | |
GC32465-50mg |
|
959551-10-1 |
NIH-12848
|
0 | C20H14F3N3S | |